Global Troponin Market, By Product Type (Troponin I, Troponin T, Troponin Complex, and Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, and Others), By End User (Hospitals, Diagnostics Labo

Global Troponin Market, By Product Type (Troponin I, Troponin T, Troponin Complex, and Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, and Others), By End User (Hospitals, Diagnostics Laboratories, Home Care Settings, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

The global troponin market was valued at US$ 1.38 Bn in 2023 and is expected to reach US$ 3.55 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.

Figure 1. Global Troponin Market Share (%), by Region, 2024

The global troponin market has been witnessing significant growth over the past few years owing to the rising prevalence of cardiovascular diseases worldwide. Troponins play a vital role in the diagnosis of myocardial infarction and cardiac injury. Troponin is a protein found in heart muscles that is released when the heart is damaged. Troponin testing is considered the gold standard for diagnosing heart attack as it is more sensitive and specific than other biomarkers. Various developments in healthcare infrastructure and growing adoption of advanced cardiac diagnostic technologies among healthcare providers have augmented the demand for troponin assays globally. Troponin tests are mostly carried out at the emergency department. When a patient arrives at the emergency department (ED) with chest pain and no or unclear changes on the electrocardiogram (ECG), the ED physician typically orders serial troponin tests. This is to establish if the symptoms are caused by an acute myocardial infarction (AMI) - a heart attack. Furthermore, increasing investments by key players in the development and commercialization of high sensitivity troponin tests with improved accuracy are expected to drive the market growth during the forecast period.

Market Dynamics:

The key drivers fueling the growth of the global troponin market are rapid growth in geriatric population who are more prone to cardiovascular issues, rising awareness regarding early diagnosis of heart conditions, and increasing healthcare expenditure in developing nations. However, stringent regulatory approvals and reimbursement policies pose a major challenge for market players. Meanwhile, the development of novel troponin tests with simplified workflow and rapid results presents significant opportunities in the market. Troponins are cardiac biomarkers used in the diagnosis of myocardial infarction. The global troponin diagnostics market has grown steadily in recent years due to the increasing prevalence of cardiovascular diseases worldwide.

Key features of the study:

• This report provides an in-depth analysis of the global troponin market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global troponin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Teleflex Incorporated, Ambu, Medtronic, Thermo Fisher Scientific, Intersurgical, Legend Medical Devices, BD, Vogt Medical, Asid Bonz, Hsiner, and other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global troponin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global troponin market

Detailed Segmentation:

• By Product Type
• Troponin I
• Troponin T
• Troponin Complex
• Others (Troponin C)
• By Application
• Myocardial Infarction
• Acute Coronary Syndrome
• Congestive Heart Failure
• Cardiomyopathy
• Others (Pulmonary Embolism)
• By End User
• Hospitals
• Diagnostics Laboratories
• Home Care
• Others (Doctor's Clinics)
• By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Top Companies in the Global Troponin Market
• Roche Diagnostics
• Abbott Laboratories
• Beckman Coulter
• Response Biomedical
• Vitro
• Siemens Healthcare GmbH
• Radiometer Medical ApS
• bioMérieux SA
• Thermo Fisher Scientific
• Mitsubishi Chemical Europe
• Other Prominent Players